# A commentary on GST reforms and their effect on cancer care in India

**Authors:** Vaibhav Sahni, Abhishek Shankar

PMC · DOI: 10.3389/fpubh.2026.1758151 · Frontiers in Public Health · 2026-02-04

## Full-text entities

- **Diseases:** cancer (MESH:D009369), rare (MESH:D035583)
- **Chemicals:** Asciminib (MESH:C000621806), Irinotecan (MESH:D000077146), Atezolizumab (MESH:C000594389), Alectinib (MESH:C582670), Azetolizumab (-), Daratumumab (MESH:C556306), alcohol (MESH:D000438), Amivantamab (MESH:C000718215)
- **Species:** Nicotiana tabacum (American tobacco, species) [taxon 4097], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12913365/full.md

## References

10 references — full list in the complete paper: https://tomesphere.com/paper/PMC12913365/full.md

---
Source: https://tomesphere.com/paper/PMC12913365